Muscarinic receptors in the ocular surface

被引:8
作者
Enriquez-de-Salamanca, Amalia [1 ]
Calonge, Margarita [1 ]
机构
[1] Univ Valladolid, Fac Med, Ocular Surface Grp, IOBA,Inst Appl Ophthalmobiol, Valladolid 47005, Spain
关键词
conjunctiva; eye; muscarinic; neurogenic inflammation;
D O I
10.1097/01.all.0000244800.71851.0c
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review A wide distribution of the eye's muscarine receptor system has been found and several roles for the muscarinic system in the eye proposed, although functional consequences of muscarinic receptor activation are not always fully characterized. The present paper reviews current knowledge about the presence of muscarinic receptors in the ocular surface and the implication of the alterations on their expression and/or functioning in eye diseases. Recent findings Several authors have described alterations in muscarinic receptor subtype expression in the eye under pathological conditions. In conjunctiva of vernal keratoconjunctivitis patients, the expression of muscarinic receptor subtypes is altered in both the epithelium and stroma. Under proinflammatory conditions, M-muscarinic receptor expression is upregulated in conjunctival epithelial cells in vitro. M3-muscarinic receptor altered distribution has been found in the lacrimal gland NOD mice. Summary The cholinergic muscarinic system plays diverse roles. Alterations in the expression and/or functioning of muscarinic receptors may be implicated in the etiopathogenesis of some ocular diseases. Their pharmacological regulation may therefore have therapeutic value. Knowledge of the specific receptor subtypes expressed in each tissue may help to avoid some undesired secondary side effects in some cases when muscarinic agonists or antagonists are used.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 33 条
  • [21] LIND GJ, 1995, INVEST OPHTH VIS SCI, V36, P1492
  • [22] Altered expression of neurotransmitter receptors and neuromediators in vernal keratoconjunctivitis
    Motterle, L
    Diebold, Y
    de Salamanca, AE
    Saez, V
    Garcia-Vazquez, C
    Stern, ME
    Calonge, M
    Leonardi, A
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (04) : 462 - 468
  • [23] Muscarinic receptor functioning and distribution in the eye:: Molecular basis and implications for clinical diagnosis and therapy
    Nietgen, GW
    Schmidt, J
    Hesse, L
    Hönemann, CW
    Durieux, ME
    [J]. EYE, 1999, 13 (3) : 285 - 300
  • [24] Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: A randomized, double-blind clinical study
    Ono, M
    Takamura, E
    Shinozaki, K
    Tsumura, T
    Hamano, T
    Magi, Y
    Tsubota, K
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (01) : 6 - 17
  • [25] Ríos JD, 1999, INVEST OPHTH VIS SCI, V40, P1102
  • [26] Ríos JD, 2000, INVEST OPHTH VIS SCI, V41, P2127
  • [27] Muscarinic and purinergic Ca2+ mobilizations in the neural retina of early embryonic chick
    Sakaki, Y
    Fukuda, Y
    Yamashita, M
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1996, 14 (06) : 691 - 699
  • [28] Recent advances in the management of ocular complications of Sjogren's syndrome
    Samarkos, M
    Moutsopoulos, HM
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2005, 5 (04) : 327 - 332
  • [29] The pathology of dry eye: The interaction between the ocular surface and lacrimal glands
    Stern, ME
    Beuerman, RW
    Fox, RI
    Gao, JP
    Mircheff, AK
    Pflugfelder, SC
    [J]. CORNEA, 1998, 17 (06) : 584 - 589
  • [30] WALKENBACH RJ, 1990, INVEST OPHTH VIS SCI, V31, P702